| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/2008 | CN101249080A Acetylkitasamycin dispersible tablet and method of preparing the same |
| 08/27/2008 | CN101249079A Andrographolide succinic acid half-ester natrium potassium salt and preparations |
| 08/27/2008 | CN101249078A Sodium rebeprazole freeze-dried injection |
| 08/27/2008 | CN101249076A Arbidol granular formulation and fluidized-bed coating preparation thereof |
| 08/27/2008 | CN101249075A Preparation of water-soluble hypocrellin earth silicon nano granule based on hypocrellin nano crystal |
| 08/27/2008 | CN101249074A Aztreonam liposomes freeze-dry preparations and method of preparing the same |
| 08/27/2008 | CN101249073A Pantoprazole sodium liposomes freeze-dry preparations and method of preparing the same |
| 08/27/2008 | CN101249072A Method for preparing liposomes containing soya bean lecithin rhodiola rosea glycosides with melting method |
| 08/27/2008 | CN101249071A Preparation of 2-methoxyl group estradiol vena nano emulsions |
| 08/27/2008 | CN101249070A 2-methoxy estradiol vena nano emulsions |
| 08/27/2008 | CN101249069A Tilmicosin long-acting injection and method of preparing the same |
| 08/27/2008 | CN101249068A Ivermectin long-acting injection and method of preparing the same |
| 08/27/2008 | CN101249067A Anticancer sustained-release injection containing tumour medicament-resistant reverse agent and cell toxicity medicament |
| 08/27/2008 | CN101249065A Gelatin for Balofloxacin eye and method of preparing the same |
| 08/27/2008 | CN101249063A Calciparine/sodium salt nano oral preparation and preparation technique thereof |
| 08/27/2008 | CN101249062A Fibraurea stem element jelly glue preparations and preparation technique thereof |
| 08/27/2008 | CN100413975C Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product |
| 08/27/2008 | CN100413961C Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/27/2008 | CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/27/2008 | CN100413881C Eplerenone crystalline form |
| 08/27/2008 | CN100413878C Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/27/2008 | CN100413877C Helicid modifier and its preparation method and uses |
| 08/27/2008 | CN100413876C Epimeridinoside A and epimeredi indica root extract preparation containing same and preparing method therefor |
| 08/27/2008 | CN100413874C Novel water soluble Pt (II) anti-cancer ligand and its preparing method |
| 08/27/2008 | CN100413868C Compounds separated from gamboges with activities of inhibiting tumour/cancer cell growth and pharmaceutical compositions containing same |
| 08/27/2008 | CN100413867C 4-amino-5-phenyl-7-cyclohexyl-pyrrolo[2,3-d]pyrimidine derivatives |
| 08/27/2008 | CN100413866C Riboflavin derivative and its preparation method and uses |
| 08/27/2008 | CN100413864C [1,7]naphthyridines as PDE4 inhibitors |
| 08/27/2008 | CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
| 08/27/2008 | CN100413862C Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use |
| 08/27/2008 | CN100413861C Compounds and methods for the treatment or prevention of flavivirus infections |
| 08/27/2008 | CN100413860C Piperidine derivative as NMDA receptor antagonist |
| 08/27/2008 | CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same |
| 08/27/2008 | CN100413852C Valsartan salts |
| 08/27/2008 | CN100413850C Chemical compounds |
| 08/27/2008 | CN100413849C Benzimidazole derivatives |
| 08/27/2008 | CN100413845C Compounds for modulating cell proliferation |
| 08/27/2008 | CN100413835C Compounds for the suppression of HIV TAT transactivation |
| 08/27/2008 | CN100413539C The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 08/27/2008 | CN100413523C Anal fistula treating Chinese medicine |
| 08/27/2008 | CN100413517C Neck plaster |
| 08/27/2008 | CN100413513C Medication for treating neonatal jaundice, and method of use |
| 08/27/2008 | CN100413512C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 08/27/2008 | CN100413510C Mannosan peptide injection and preparation method thereof |
| 08/27/2008 | CN100413509C Use of lambda-carrageenan oligose in preparing blood vessel proliferation inhibitor |
| 08/27/2008 | CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 08/27/2008 | CN100413507C 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteopenia or male osteoporosis |
| 08/27/2008 | CN100413506C Improved pharmaceutical compositions |
| 08/27/2008 | CN100413505C Gel agent for treating glaucoma and its preparing process |
| 08/27/2008 | CN100413504C Medicinal resin biological adhering slow-releasing liquid prepn. contg. aciclovir, and its preparation method |
| 08/27/2008 | CN100413503C Compound ocular medicinal composition |
| 08/27/2008 | CN100413502C Hypertension treating medicine |
| 08/27/2008 | CN100413501C Transdermal absorptive anemonin plaster |
| 08/27/2008 | CN100413500C Medicine for preventing or treating osteoporosis and its preparing process and application |
| 08/27/2008 | CN100413499C A nanoemulsion medicine of eugenol and preparation method thereof |
| 08/27/2008 | CN100413498C Drop pills of soybean aglycone, and preparation method |
| 08/27/2008 | CN100413497C Water soluble soybean aglycone medicinal composition and its preparing method |
| 08/27/2008 | CN100413496C The use of sussinate derivative esters for the treatment of dementia |
| 08/27/2008 | CN100413495C Medical use of 2 alpha, 3 beta-dihydroxy-5, 11(13)- diallyl eudesmane-12 acid for inhibiting hepatitis B virus |
| 08/27/2008 | CN100413494C Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 08/27/2008 | CN100413493C Use of gossypol and its derivative in preparation of drug for leukemia / bone marrow cancer |
| 08/27/2008 | CN100413492C Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| 08/27/2008 | CN100413491C Sustained release preparation of solution resistant medicine |
| 08/26/2008 | US7417169 Amino alcohol derivatives, medicinal composition containing the same, and use of these |
| 08/26/2008 | US7417159 Conjugated linolenic acids and methods of preparation and purification and uses thereof |
| 08/26/2008 | US7417158 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens |
| 08/26/2008 | US7417156 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma |
| 08/26/2008 | US7417150 Azoles having an insecticidal action |
| 08/26/2008 | US7417148 Enzyme inhibitors for treatment of cancer leukemia |
| 08/26/2008 | US7417144 e.g. 1-Methyl-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazole-4,5-dicarboxylic acid 5-[(4-chloro-phenyl)-amide]4-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, antiinflammatory agent; thrombosis, peripheral arterial occlusive disease, stroke, arteriosclerosis, bypass grafting |
| 08/26/2008 | US7417140 17 beta -Hydroxy-7 alpha -(2'-hydroperoxy-2'-methoxyacetyl)pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma -lactone chemical intermediate useful to prepare eplerenone a hypotensive agent, useful for treating congestive heart failure |
| 08/26/2008 | US7417136 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 08/26/2008 | US7417129 Combinatorial libraries of monosaccharides |
| 08/26/2008 | US7417118 Pharmaceutical composition containing artificial oxygen carrier |
| 08/26/2008 | US7417113 Antitumor agents; anticancer agents; antibody binding |
| 08/26/2008 | US7417109 Polymers for delivering nitric oxide in vivo |
| 08/26/2008 | US7417072 Blockade of Pin1 prevents cytokine production by activated immune cells |
| 08/26/2008 | US7417071 delivers essential or beneficial fatty acids in an optimal manner with respect to stability and biosorptivity |
| 08/26/2008 | US7417070 Compounds and methods for delivery of prostacyclin analogs |
| 08/26/2008 | US7417069 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 08/26/2008 | US7417068 EP4 receptor antagonists |
| 08/26/2008 | US7417067 mixtures of bicyclic compounds such as lubiprostone, and triglycerides; bronchodilator agents; eye drops, capsules |
| 08/26/2008 | US7417066 Inhibitors of soluble adenylate cyclase |
| 08/26/2008 | US7417065 Therapy, prevention of lymphocyte causing disease; antiinflammatory agents; autoimmune disease |
| 08/26/2008 | US7417064 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| 08/26/2008 | US7417063 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent |
| 08/26/2008 | US7417062 e.g. N (S)-(1-Cyclohexylmethyl-pyrrolidine-2-ylmethyl)-3,4-dimethoxy-N-naphthalen-2-ylmethyl-benzamide; inhibit the binding of the SDF-1 (CXCL12) chemokine or I-TAC (CXCL11) to the chemokine receptor CCXCKR2; anticarcinogenic agent; breast, lymph nodes, bone marrow, and lungs cancer |
| 08/26/2008 | US7417061 Amino acid for devivering active materials; bioavailability; mixture containing oxadiazole compound |
| 08/26/2008 | US7417060 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid |
| 08/26/2008 | US7417059 Substituted aromatic-ring compounds, process for producing the same and use |
| 08/26/2008 | US7417058 Reacting cyanophenyl-4-sulfonylchloride with a piperidine-4-oxo in presence of ethylene glycol to form an intermediate, reducing cyano group, followed by amidation, then reacting with an amine to form sulfonamide end |
| 08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
| 08/26/2008 | US7417056 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents |
| 08/26/2008 | US7417055 Pharmacokinetics; bioavailability |
| 08/26/2008 | US7417054 Naphthyridine compounds |
| 08/26/2008 | US7417053 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
| 08/26/2008 | US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 08/26/2008 | US7417051 9,9-dimethyl-3-oxa-9-azoniumtricyclo(3.3.1.0(2,4))nonanyl 2,2-diphenylpropionate quaternary salt |
| 08/26/2008 | US7417050 Cognition activators; Alzheimer's disease; attention deficit disorders; Parkinson's disease; Huntington's disease; neurodegenerative disease |
| 08/26/2008 | US7417049 Furyl compounds |